Objective: To identify the risk of brucellosis in the state of Tlaxcala, Mexico.

Materials And Methods: A diagnosis of social type was conducted in the municipalities of Huamantla, Ixtenco and Teacalco, located in the eastern region of the state. The seroprevalence of brucellosis in goats and humans was determined.

Results: 46.9% of producers know the programs of vaccination against brucellosis; 19.7% apply the vaccine and 80.3% do not apply the vaccine. Huamantla had the highest seroprevalence of animal brucellosis in 66.8%; San Jose Teacalco distributes unpasteurized cheeses to a distance of 270 km, increasing the risk of infection with brucellosis. Ixtenco recorded the highest prevalence of brucellosis in humans, with 1.51%.

Conclusion: The municipalities studied present risks of infection and spread of brucellosis.

Download full-text PDF

Source

Publication Analysis

Top Keywords

apply vaccine
8
brucellosis
7
[risk analysis
4
analysis brucelosis
4
brucelosis state
4
state tlaxcala]
4
tlaxcala] objective
4
objective identify
4
identify risk
4
risk brucellosis
4

Similar Publications

Purpose: Outer membrane vesicles (OMVs) derived from Gram-negative bacteria naturally serve as a heterologous nano-engineering platform, functioning as effective multi-use nanovesicles for diagnostics, vaccines, and treatments against pathogens. To apply refined OMVs for human theranostic applications, we developed naturally exposed receptor-binding domain (RBD) OMVs grafted with antigen 43 as a minimal modular system targeting angiotensin-converting enzyme 2 (ACE2).

Methods: We constructed -derived OMVs using the antigen 43 autotransporter system to display RBD referred to as viral mimetic Ag43β700_RBD OMVs.

View Article and Find Full Text PDF

Multi-platform diagnostic strategy and biosecurity as basis of contagious agalactia control programs in endemic areas.

Ir Vet J

January 2025

Departamento de Sanidad Animal, Facultad de Veterinaria, Universidad de Murcia, Campus de Espinardo s/n., Murcia, 30100, Spain.

Background: Control strategies against contagious agalactia (CA), considered one of the most important diseases affecting small ruminants in countries surrounding the Mediterranean, are mainly based on traditional strategies considered suboptimal such as the use of inactivated vaccines and antibiotics. This manuscript analysed the efficacy of an alternative non-mandatory official control programme based on a multi-platform diagnostic panel and biosecurity developed and started in 185 herds placed in a contagious agalactia endemic area of Spain, using the data of 74,080 samples collected and analysed during a 4 years-period (2018-2021).

Results: Globally, the combined analyses of bulk tank milk (BTM), ear or nasal swabs (in goats or sheep, respectively) and the serology to detect Mycoplasma agalactiae (Ma), allowed the detection of 40.

View Article and Find Full Text PDF

Vaccination is the most effective method of preventing and controlling the transmission of infectious diseases within populations. However, the phenomenon of waning immunity can induce periodic fluctuations in epidemic spreading. This study proposes a coupled epidemic-vaccination dynamic model to analyze the influence of immunity waning on the epidemic spreading within the context of voluntary vaccination.

View Article and Find Full Text PDF

Background: The COVID-19 pandemic has highlighted the need for more effective immunization programs, including in limited resource settings. This paper presents outcomes and lessons learnt from a COVID-19 vaccination campaign (VC), which used a tailored adaptive strategy to optimise vaccine uptake in the Boeny region of Madagascar.

Methods: Guided by the Dynamic Sustainability Framework (DSF), the VC implementation was regularly reviewed through multi-sectoral stakeholder feedback, key informant interviews, problem-solving meetings, and weekly monitoring of outcome indicators to identify and apply key adaptations.

View Article and Find Full Text PDF

Introduction: Most studies on risk factors for a SARS-CoV-2 infection were conducted in the pre-vaccination era with many non-pharmaceutical prevention measures in place. We investigated risk factors for symptomatic SARS-CoV-2 infections in vaccinated persons in a period with a varying degree of prevention measures.

Methods: In a test-negative case control study among vaccinated adults attending community COVID-19 testing locations between June 1st 2021 till February 28th 2022, we compared symptomatic cases with symptomatic controls (to study risk factors specific for SARS-CoV-2) and with asymptomatic controls (to study risk factors that could apply to respiratory infections in general).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!